Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 15, 2024 2:17 PM 2 min read

See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina

by Vandana Singh Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

Friday, the Agency for Health Care Administration announced contracts to five health plans due for the re-procurement of the Statewide Medicaid Managed Care (SMMC) program. 

Florida has finally announced its long-awaited Medicaid contract awards, keeping Centene Inc (NYSE:CNC), Elevance Health Inc (NYSE:ELV), and Humana Inc (NYSE:HUM) as the only providers in each state region. 

Stephens noted that Centene and Elevance Health re-procured specialty contracts (MMASC) while Centene also retained its child welfare (MMACC) contract.

This decision sidelines UnitedHealth Group Inc (NYSE:UNH), CVS Health Corp (NYSE:CVS), and Molina Healthcare Inc (NYSE:MOH) from the state’s Medicaid market. Centene stands to benefit the most, maintaining its dominant position. 

The contract spans six years and is slated to commence in October.

Florida law mandates that SMMC health plans be re-procured every six years; this was the second re-procurement. 

Through a regular, established competitive procurement process, the Agency negotiated and selected health plans to provide Managed Medical Assistance (MMA) and Long-term Care (LTC) services to the more than 3.4 million Florida people enrolled in the SMMC program.

Stephens adds that the results suggest the best possible outcome in Centene’s expected scenario of member loss. 

They recommend increasing the company’s overall share of Florida Medicaid. Additionally, the analyst anticipates Elevance Health and Humana will increase their membership by approximately 28% and 26%, respectively.

Oppenheimer writes that this outcome is ideal for Centene as it maintains its market share, exceeding expectations of substantial losses despite its high market presence.

Oppenheimer notes that Humana was a large beneficiary with around 147k members.

CVS Health, UnitedHealth, and Molina missed out, possibly prompting protests that could delay the implementation start date until January 1, 2025. 

Overall, the market will likely view the re-procurement as a major success for CNC, which should boost its stock, particularly considering recent letdowns in smaller re-procurements.

Price Action: CNC shares are up 3.23% at $73.02, and MOH shares are down 4.65% at $359.07 on the last check Monday.

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
Analyst ColorGovernmentLarge CapNewsHealth CareMarketsAnalyst RatingsMoversTrading IdeasGeneralBriefsExpert IdeasStories That Matterwhy it's moving
CNC Logo
CNCCentene Corp
$43.14-0.41%
Overview
CVS Logo
CVSCVS Health Corp
$74.37-0.20%
ELV Logo
ELVElevance Health Inc
$345.74-%
HUM Logo
HUMHumana Inc
$195.500.15%
MOH Logo
MOHMolina Healthcare Inc
$176.63-1.65%
UNH Logo
UNHUnitedHealth Group Inc
$286.28-0.23%
CNC Logo
CNCCentene Corp
$43.14-0.41%
Overview
CVS Logo
CVSCVS Health Corp
$74.37-0.20%
ELV Logo
ELVElevance Health Inc
$345.74-%
HUM Logo
HUMHumana Inc
$195.500.15%
MOH Logo
MOHMolina Healthcare Inc
$176.63-1.65%
UNH Logo
UNHUnitedHealth Group Inc
$286.28-0.23%
Comments
Loading...